Works by Xingyu Xu


Results: 42
    1
    2
    3
    4
    5

    HLA-A<sup>+</sup> tertiary lymphoid structures with reactivated tumor infiltrating lymphocytes are associated with a positive immunotherapy response in esophageal squamous cell carcinoma.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 1, p. 184, doi. 10.1038/s41416-024-02712-9
    By:
    • Zhang, Dandan;
    • Jiang, Dongxian;
    • Jiang, Liping;
    • Ma, Jiakang;
    • Wang, Xiaobing;
    • Xu, Xingyu;
    • Chen, Ziqiang;
    • Jiang, Mengping;
    • Ye, Wenjing;
    • Wang, Jie;
    • Meng, Weida;
    • Qiu, Wenqing;
    • Hou, Yingyong;
    • Huang, Jing;
    • Jiao, Yuchen;
    • Liu, Yun;
    • Liu, Zhihua
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Molecular Network-Based Drug Prediction in Thyroid Cancer.

    Published in:
    International Journal of Molecular Sciences, 2019, v. 20, n. 2, p. 263, doi. 10.3390/ijms20020263
    By:
    • Xu, Xingyu;
    • Long, Haixia;
    • Xi, Baohang;
    • Ji, Binbin;
    • Li, Zejun;
    • Dang, Yunyue;
    • Jiang, Caiying;
    • Yao, Yuhua;
    • Yang, Jialiang
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42